The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Turner Christopher Durant since 2022.
This trader's CIK number is 1862146.
At the time of last reporting, Turner Christopher Durant was the Chief Medical Officer of Nuvalent, Inc.. (stock ticker symbol NUVL).
Also see all insider trading activities at Nuvalent, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | NUVL | 0 | $0 | 4,016 | $318,802 | 0 | $0 |
| 2023 | NUVL | 0 | $0 | 23,560 | $1,154,188 | 23,560 | $162,326 |
| 2022 | NUVL | 0 | $0 | 0 | $0 | 14,513 | $99,994 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-01-06 | NUVL | Sale | 4,016 | 79.38 | 318,802 |
| 2023-10-04 | NUVL | Option Ex | 7,995 | 6.89 | 55,085 |
| 2023-10-04 | NUVL | Sale | 7,995 | 55.01 | 439,804 |
| 2023-07-28 | NUVL | Sale | 2,665 | 48.93 | 130,398 |
| 2023-07-26 | NUVL | Option Ex | 2,365 | 6.89 | 16,294 |
| 2023-07-26 | NUVL | Sale | 2,365 | 46.85 | 110,800 |
| 2023-07-28 | NUVL | Option Ex | 2,665 | 6.89 | 18,361 |
| 2023-07-20 | NUVL | Option Ex | 100 | 6.89 | 689 |
| 2023-07-20 | NUVL | Sale | 100 | 46.80 | 4,680 |
| 2023-07-24 | NUVL | Option Ex | 200 | 6.89 | 1,378 |
| 2023-07-24 | NUVL | Sale | 200 | 46.82 | 9,364 |
| 2023-06-05 | NUVL | Option Ex | 10,235 | 6.89 | 70,519 |
| 2023-06-05 | NUVL | Sale | 10,235 | 44.86 | 459,142 |
| 2022-05-17 | NUVL | Option Ex | 14,513 | 6.89 | 99,994 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Turner Christopher Durant (Chief Medical Officer of Nuvalent, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.